KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Treasury Shares (2017 - 2025)

Twist Bioscience (TWST) has disclosed Treasury Shares for 7 consecutive years, with $1.7 million as the latest value for Q2 2023.

  • On a quarterly basis, Treasury Shares rose 33.04% to $1.7 million in Q2 2023 year-over-year; TTM through Jun 2023 was $1.7 million, a 33.04% increase, with the full-year FY2021 number at $707.0, down 64.65% from a year prior.
  • Treasury Shares was $1.7 million for Q2 2023 at Twist Bioscience, down from $1.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.8 million in Q1 2023 to a low of -$1000.0 in Q1 2020.
  • A 5-year average of $496379.2 and a median of $2000.0 in 2020 define the central range for Treasury Shares.
  • Biggest YoY gain for Treasury Shares was 11100100.0% in 2020; the steepest drop was 126.24% in 2020.
  • Twist Bioscience's Treasury Shares stood at -$1.0 in 2019, then soared by 11100100.0% to $111000.0 in 2020, then tumbled by 98.55% to $1605.0 in 2021, then surged by 113171.03% to $1.8 million in 2022, then dropped by 8.09% to $1.7 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Treasury Shares are $1.7 million (Q2 2023), $1.8 million (Q1 2023), and $1.8 million (Q4 2022).